Jeffrey Strovel
Impact in
- Hematology top 10%
- Multiple Myeloma Research and Treatments
-
- Protein Degradation and Inhibitors
- Ubiquitin and proteasome pathways
- Histone Deacetylase Inhibitors Research
- Cancer-related gene regulation
- Wnt/β-catenin signaling in development and cancer
Papers in
-
- Protein Degradation and Inhibitors 9
- Histone Deacetylase Inhibitors Research 5
- Biochemical and Molecular Research 4
- Ubiquitin and proteasome pathways 2
- Hematology 10
- Multiple Myeloma Research and Treatments 7
- Chronic Myeloid Leukemia Treatments 3
- Co-authors
- Makoto Yoshioka (7 shared papers)Steven Fletcher (5 shared papers)Jeremy L. Yap (1 shared paper)Maryanna E. Lanning (1 shared paper)Lijia Chen (1 shared paper)Mithun Raje (2 shared papers)Eishi Ashihara (6 shared papers)Miki Takeuchi (4 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (3 papers)Blood (3 papers)Cancer Research (2 papers)Journal of Clinical Oncology (2 papers)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- United StatesJapanPuerto Rico
In The Last Decade
Jeffrey Strovel
24 papers receiving 357 citations
Peers
Comparison fields: 5 of 63
- Hematology 94
- Molecular Biology 265
- Oncology 59
- Genetics 20
- Cancer Research 25
Countries citing papers authored by Jeffrey Strovel
This map shows the geographic impact of Jeffrey Strovel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Strovel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Strovel more than expected).
Fields of papers citing papers by Jeffrey Strovel
This network shows the impact of papers produced by Jeffrey Strovel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Strovel. The network helps show where Jeffrey Strovel may publish in the future.
Co-authors
The 25 scholars most cited alongside Jeffrey Strovel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 77 | |
| 2 | 2018 | 47 | |
| 3 | 2011 | 43 | |
| 4 | Early Drug Discovery and Development Guidelines: For Academic Researchers, Collaborators, and Start-up Companies | 2016 | 33 |
| 5 | 1999 | 24 | |
| 6 | 2011 | 19 | |
| 7 | 2017 | 18 | |
| 8 | 1999 | 15 | |
| 9 | 2018 | 13 | |
| 10 | 2021 | 11 | |
| 11 | 2019 | 10 | |
| 12 | 2018 | 10 | |
| 13 | 2006 | 10 | |
| 14 | 2005 | 9 | |
| 15 | Quantitative measurement of telomerase activity in lymphadenopathy: correlation with histologic features and human immunodeficiency virus-1 infection. | 1998 | 4 |
| 16 | 2007 | 3 | |
| 17 | 2008 | 3 | |
| 18 | 2008 | 3 | |
| 19 | 2009 | 2 | |
| 20 | Antiangiogenic properties of the IMPDH inhibitor AVN944 | 2007 | 2 |
About Jeffrey Strovel
Jeffrey Strovel is a scholar working on Molecular Biology, Hematology, Public Health, Environmental and Occupational Health, Pathology and Forensic Medicine and Genetics, having authored 24 papers that have together received 360 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (9 papers), Multiple Myeloma Research and Treatments (7 papers), Histone Deacetylase Inhibitors Research (5 papers), Biochemical and Molecular Research (4 papers), Chronic Myeloid Leukemia Treatments (3 papers), Acute Lymphoblastic Leukemia research (3 papers), Ubiquitin and proteasome pathways (2 papers) and HIV/AIDS drug development and treatment (2 papers). The work is most often cited by research in Hematology (94 citations), Molecular Biology (265 citations), Oncology (59 citations), Genetics (20 citations) and Cancer Research (25 citations). Jeffrey Strovel has collaborated with scholars based in United States, Japan and Puerto Rico. Frequent co-authors include Makoto Yoshioka, Steven Fletcher, Jeremy L. Yap, Maryanna E. Lanning, Lijia Chen, Mithun Raje, Eishi Ashihara, Miki Takeuchi, J. Stamberg and Hisayuki Yao. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Blood, Cancer Research, Journal of Clinical Oncology and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.